CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).
Author
Alex Morozov
Alexia Iasonos
+17Â more
Christina Marie Coughlin
Clifford A. Hudis
Gary Ulaner
Jose Baselga
Joy Ero
Mary Ellen Moynahan
Maura N. Dickler
Michael F. Berger
Monica Nancy Fornier
Nancy T. Sklarin
Neal Rosen
Payal Deepak Shah
Sarat Chandarlapaty
Shanu Modi
Stephen James Zamora
Teresa Gilewski
Valentina Sterlin
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref